Health Dictionary Find a Doctor

Lower gastrointestinal bleeding

For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Synonyms and keywords: LIGB; Lower GI bleed; Acute lower gastrointestinal bleeding; Intestinal bleeding; Lower gastrointestinal hemorrhage

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Lower gastrointestinal bleeding is defined as blood loss originating distal to the ligament of Treitz. It accounts for 24% to 33% of all hospital admissions for gastrointestinal bleeding and is responsible for 1% of hospital admissions in the United States. It can present with frank blood loss per rectum or may be occult in nature, presenting with anemia. Bleeding can vary in severity from passage of small amounts of blood to massive life-threatening hemorrhage. Acute LGIB is described as bleeding of recent onset, which may result in hemodynamic instability and need for blood transfusion. Most commonly originates in the colon or anorectum; only 5% arise in the small bowel. Etiologies vary among adult, elderly, and pediatric populations. Ninety percent of lower gastrointestinal bleeding stop spontaneously; however, the underlying etiology needs to be diagnosed and treated accordingly. Overall mortality is less than 4%, but may be higher in elderly populations and in those with comorbid disease. Even bleeding of moderate rate can have significant sequel in a group of patients with the comorbid disease. A thorough history and detailed examination are essential steps in establishing the cause and the source of bleeding. Patients with severe bleeding or hemodynamic disturbance require hospitalization and urgent investigation. It is essential to distinguish between lower gastrointestinal bleeding and brisk upper gastrointestinal bleeding as they can present with similar symptoms. Treatment depends on the cause and the severity of the bleeding.

Historical Perspective

Roman encyclopedist, Aulus Cornelius Celsus, was the first to describe band ligation treatment for hemorrhoidal bleeding. In the 1700s, Alexis Littre described the association between diverticular diseases and bleeding. In 1885, Allchin gave a detailed description of ulcerative colitis which can present with bleeding. Until 1967, mesenteric ischemia was a diagnostic dilemma. In 1887, Welch proposed that ischemic bowel changes occur secondary to 80% stenosis of superior mesenteric artery (SMA) resulting in bleeding as a complication.

Classification

Lower gastrointestinal bleeding may be classified based on the severity of bleeding into occult, moderate and severe bleeding.

Pathophysiology

Superior mesenteric artery and inferior mesenteric artery are the two major blood vessels that supply lower gastrointestinal tract. Disruption of this blood vessel junction by any of the disease process results in bleeding. Diverticulosis is the most common etiology of lower GI bleeding accounting for 30% of all cases, followed by ano-rectal disease, ischemia of bowel, inflammatory bowel disease (IBD), neoplasia, and arteriovenous (AV) malformations. The characteristic gross and microscopic findings of lower gastrointestinal tracts depends upon the underlying pathology.

Causes

Common causes of lower gastrointestinal tract bleeding include diverticulosis, angiodysplasia, ischemic colitis, colorectal cancer, anorectal diseases, infectious colitis and inflammatory bowel disease. Less common causes of lower gastrointestinal tract include colonic polyps, radiation proctitis, and rectal varices.

Differentiating lower gastrointestinal bleeding from Other Diseases

Several diseases present with lower gastrointestinal bleeding and must be differentiated from each other. The common diseases responsible for lower GI bleeding include diverticulosis, angiodysplasia, hemorrhoids, anal fissures, mesenteric Ischemia, ischemic colitis, inflammatory bowel disease, and colo-rectal carcinoma.

Epidemiology and Demographics

The prevalence of lower gastrointestinal bleeding is approximately 20 per 100,000 population in the United States. Lower gastrointestinal bleed is more common in men than women.

Risk Factors

Common risk factors in the development of lower GI bleeding include advancing age, previous history of gastrointestinal bleed, chronic constipation, hematologic disorders, anticoagulants medications, non-steroidal anti-inflammatory drugs, and human immunodeficiency virus infection.

Screening

There is insufficient evidence to recommend routine screening for lower gastrointestinal bleeding.

Natural History, Complications, and Prognosis

If left untreated 90% of the time lower gastrointestinal bleeding is usually self-limited. However, massive blood loss can result in a severe drop in blood pressure resulting in decreased blood supply to organ systems leading to death. Hypovolemic shock and symptomatic anemia are the most common direct complications of LGIB. Prognosis is generally good, and the 1-year mortality rate of patients with lower gastrointestinal bleeding is less than four percent.

Diagnosis

Diagnostic Study of Choice

Colonoscopy is the gold standard test for the diagnosis of lower gastrointestinal bleeding. However, Endoscopy is the investigation of choice in cases of lower gastrointestinal bleeding caused by ischemic colitis or colonoscopy is unequivocal.

History and Symptoms

The hallmark symptom of LGIB is bleeding per rectum or frank blood in stools. The presentation of associated symptoms depends upon the source of the bleeding and underlying etiology. Associated symptoms of lower gastrointestinal bleeding include fever, abdominal pain, bloody diarrhea, dehydration, history of constipation, and hypotension in severe cases, and weight loss. A detailed description of the nature of the blood loss can also help in pinpointing the likely source of bleeding.

Physical Examination

The most common physical examination finding is the passage of frank blood per rectum (hematochezia).

Laboratory Findings

The essential blood work in diagnosing lower gastrointestinal bleeding includes a complete blood count, renal function and liver function tests, and coagulation studies. Although not diagnostic, a blood type and crossmatch should be done in patients who present with life-threatening bleeding.

Electrocardiogram

There are no specific ECG findings associated with lower gastrointestinal bleeding. However, an electrocardiogram is be performed in order to exclude arrhythmia and cardiac causes of hypotension (following acute MI).

X-ray

There are no abdominal x-ray findings associated with lower gastrointestinal bleeding. However, an x-ray may be helpful in the diagnosing the complications of underlying disease.

Ultrasound

There are no specific ultrasound findings associated with lower gastrointestinal bleeding. However, ultrasound can be useful in diagnosing various etiology or conditions responsible for lower gastrointestinal bleeding.

CT scan

Helical CT scanning of the abdomen and pelvis is recommended when a routine workup fails to determine the cause of active gastrointestinal bleeding. Findings of helical CT scan in lower gastrointestinal bleeding include vascular extravasation of the contrast medium, contrast enhancement of the bowel wall, thickening of the bowel wall, hyperdensity of the peri-bowel fat, and vascular dilatations.

MRI

There are no MRI findings associated with lower gastrointestinal bleeding.

Other Imaging Findings

Other imaging studies include angiography and radionuclide imaging that can be helpful in diagnosing lower gastrointestinal bleeding.

Other Diagnostic Studies

Nasogastric tube lavage may be helpful in the diagnosis of lower gastrointestinal bleeding. Nasogastrictube lavage helps in differentiating lower gastrointestinal bleeding from upper gastrointestinal bleeding. Evidence of old (brown colored or ‘coffee grounds’) or fresh blood on NGT aspirate documents presence of upper gastrointestinal bleeding. Evidence of bilious material rules out bleeding distal to the pylorus.

Treatment

Medical Therapy

The aims of treatment are to resuscitate the patient, identify the source of blood loss and stop any ongoing bleeding, and reduce the risk of a recurrent bleed. It is essential to identify patients who are high risk. This would include elderly patients; those with severe ongoing bleeding or recurrent bleeding; and patients with multiple comorbid conditions, in particular, those patients with cardiac, renal, respiratory, and liver disease. Treatment depends on the mode of presentation, the severity of the bleed, and the underlying pathology. Bleeding points can be treated with endoscopy, interventional radiology, or surgery. After identification of the source of bleeding using endoscopy, therapeutic options include monopolar or bipolar diathermy, argon plasma coagulation (APC), epinephrine injections, and endoloops and hemoclips, used individually or in combination. These methods can be used to treat many of the causes of LGIB, including diverticular bleeding, angiodysplasia, radiation proctitis, and post-polypectomy bleeding interventional radiology can be used to visualize a bleeding vessel and to stop the bleeding through embolization of the vessel. Surgery may be required if less invasive measures cannot be applied or are not effective. Pharmacotherapy is only used as an adjuvant therapy for all patients with LGIB. Epinephrine is used alone or in conjunction with other surgical techniques to treat a variety of causes of LGIB.

Surgery

Emergency surgery may be needed to control bleeding in about 10% to 25% of patients in whom nonoperative management is unsuccessful or unavailable. The various endoscopic interventions employed in the management of lower gastrointestinal bleeding include argon plasma coagulation, bipolar or Heater probe, endoloops and hemoclips, and interventional radiology.

Primary Prevention

Effective measures for the primary prevention of lower GI bleeding include techniques to prevent the related conditions. Promoting a healthy lifestyle by eating a healthy diet, exercising lightly, and avoiding alcohol and tobacco can reduce the risk associated conditions.

Secondary Prevention

Secondary primary preventive measures of lower gastrointestinal bleeding is similar to primary prevention.

References


Template:WikiDoc Sources

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Roman encyclopedist Aulus Cornelius Celsus was the first to describe band ligation treatment for hemorrhoidal bleeding. In the 1700s, Alexis Littre was the first to describe the association between diverticular diseases and bleeding. In 1885, Allchin gave a detailed description of ulcerative colitis along bleeding.Until 1967, mesenteric ischemia was a diagnostic dilemma. In 1887, Welch proposed that ischemic bowel changes occur secondary to 80% stenosis of superior mesenteric artery (SMA) resulting in bleeding as a complication.

Historical perspective

References

  1. Matrana MR, Margolin DA (2009). “Epidemiology and pathophysiology of diverticular disease”. Clin Colon Rectal Surg. 22 (3): 141–6. doi:10.1055/s-0029-1236157. PMC 2780269. PMID 20676256.
  2. De Dombal FT (1968). “Ulcerative colitis: definition, historical background, aetiology, diagnosis, naturel history and local complications”. Postgrad Med J. 44 (515): 684–92. PMC 2466707. PMID 5705372.
  3. Harper DR, Buist TA (1978). “Selective angiography in acute mid-gut ischaemia”. Gut. 19 (2): 132–6. PMC 1411821. PMID 631629.
  4. Yamada, Kei; Saeki, Mitsuaki; Yamaguchi, Toshio; Taira, Makiko; Ohyama, Yukio; Ashida, Hiroshi; Sakuyama, Keiko; Ishikawa, Toru (1998). “Acute mesenteric ischemia”. Clinical Imaging. 22 (1): 34–41. doi:10.1016/S0899-7071(97)00071-5. ISSN 0899-7071.
Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Lower gastrointestinal bleeding can be classified into occult, moderate and severe bleeding based on the severity of bleeding.

Classification

Lower GI bleeding can be classified into 3 groups based on the severity of bleeding:[1][2][3][4][5][6]

  • Occult lower GI bleeding
  • Moderate lower GI bleeding
  • Severe lower GI bleeding
Severe lower GI bleeding Moderate lower GI bleeding Occult lower GI bleeding
Age > 65 years Occur at any age Any age
Presenting symptoms Hematochezia or bright red blood per rectum. Hematochezia or melena Symptoms of anemia (fatigue, tiredness)
Hemodynamics Unstable Stable Stable
Lab findings Hemoglobin equal to or less than 6 g/dl. Microcytic anemia Microcytic hypochromic anemia due to chronic blood loss.
Differential

References

  1. Lee EW, Laberge JM (2004). “Differential diagnosis of gastrointestinal bleeding”. Tech Vasc Interv Radiol. 7 (3): 112–22. PMID 16015555.
  2. Raju GS, Gerson L, Das A, Lewis B (2007). “American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding”. Gastroenterology. 133 (5): 1694–6. doi:10.1053/j.gastro.2007.06.008. PMID 17983811.
  3. Rockey DC (2010). “Occult and obscure gastrointestinal bleeding: causes and clinical management”. Nat Rev Gastroenterol Hepatol. 7 (5): 265–79. doi:10.1038/nrgastro.2010.42. PMID 20351759.
  4. Rockey DC (2005). “Gastrointestinal bleeding”. Gastroenterol. Clin. North Am. 34 (4): 581–8. doi:10.1016/j.gtc.2005.08.002. PMID 16303571.
  5. Green BT, Rockey DC (2003). “Acute gastrointestinal bleeding”. Semin. Gastrointest. Dis. 14 (2): 44–65. PMID 12889580.
  6. Rockey DC (1999). “Occult gastrointestinal bleeding”. N. Engl. J. Med. 341 (1): 38–46. doi:10.1056/NEJM199907013410107. PMID 10387941.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Superior mesenteric artery and inferior mesenteric artery are the two major blood vessels that supply lower gastrointestinal tract. Disruption of blood vessel junction, formed by these two vessels, by any of the disease process results in bleeding. Diverticulosis is the most common etiology of lower GI bleeding accounting for 30% of all cases, followed by ano-rectal disease, ischemia of bowel, inflammatory bowel disease (IBD), neoplasia, and arteriovenous (AV) malformations. The characteristic gross and microscopic findings of lower gastrointestinal tracts depends upon the underlying pathology.

Pathophysiology

Blood supply

Lower GI Tract Arterial Supply Venous Drainage
Midgut
Hindgut
ɸ -Except lower rectum, which drains into the systemic circulation.
Blood supply to the intestines includes the celiac artery, superior mesenteric artery (SMA), inferior mesenteric artery (IMA), and branches of the internal iliac artery (IIA).
Source: By Anpol42 (Own work) [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons

Pathogenesis

The pathogenesis of lower gastrointestinal bleeding can be discussed based on the etiology. Diverticulosis is the most common etiology of lower GI bleeding accounting for 30% of all cases, followed by anorectal disease, ischemia, inflammatory bowel disease (IBD), neoplasia, and arteriovenous (AV) malformations.

Diagram of sigmoid diverticulum
Source:By Anpol42 (Own work) [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons
  • Anorectal disease
  • Hemorrhoids are defined as swelling and inflammation of veins in the rectal and anal region
  • Hemorrhoids can be either internal or external based on their relation to dentate line.
  • The first step in the pathogenesis of either type of hemorrhoids is weakening of the surrounding connective tissue and vein wall.[8][9][8]
  • Weakening of blood vessels can result in bleeding under pressure.
  • An anal fissure can be defined as disruption or tear in the mucosal surface of the skin.
  • During defecation, due to increased pressure which can exaggerate the tears may present as bright red rectal bleeding with severe periodic pain.[10]
  • Mesenteric ischemia results when there is inadequate blood supply at the level of the small intestine.[11][12][13][14]
  • 2 or more vessels (celiac, SMA, or IMA) must be involved for bleeding to occur.
  • Decreased blood supply can occur due to obstruction of blood vessel either by emobolus or due to vasoconstriction effect of drugs.
  • Decreased blood supply initiates necrosis of mucosal surface of intestine.
  • unopposed blood deprivation leads to trans-mural necrosis and ultimately sloughing of the tissues with associated bleeding.
  • Ischemic colitis is a condition in which injury of the large intestine results from decreased blood supply.[15][16][17]
  • The colon is most commonly involved due the presence of water shed areas ( splenic flexure and hepatic flexure).
  • Similar to mesentric ischemia bleeding occurs due to necrosis and sloughing of mucosal membrane.
  • AV Malformation/Angiodysplasia
  • In AV malformation abnormal connections occur between arteries and veins.[32][33][34][35][36]
  • This connections results in blood flow from high pressure arteries to low pressure veins without buffering effects of capillaries.
  • The lack of capillary buffers makes the vessels weak due to increased blood flow and ultimately bleeding.
  • In Angiodysplasia, with age the connective tissue of the blood vessels become weak.
  • With mild increase in pressure leads to disrupture of vessels leading to painless bleeding.

Associated Conditions

Other diseases that are commonly associated with lower gastrointestinal bleeding include:

Gross and Microscopic Pathology

Disease Gross Pathology Microscopic Pathology
Diverticulosis[37]
Angiodysplasia[38]
Hemorrhoids[8]
  • Tortuous superficial dilatations of multiple blood vessels.
Mesenteric ischemia [39]
Ischemic colitis[39]
Crohn’s disease[40][41] 
Ulcerative colitis[42]

References

  1. Geboes K, Geboes KP, Maleux G (2001). “Vascular anatomy of the gastrointestinal tract”. Best Pract Res Clin Gastroenterol. 15 (1): 1–14. doi:10.1053/bega.2000.0152. PMID 11355897.
  2. Granger DN, Holm L, Kvietys P (2015). “The Gastrointestinal Circulation: Physiology and Pathophysiology”. Compr Physiol. 5 (3): 1541–83. doi:10.1002/cphy.c150007. PMID 26140727.
  3. “The Gastrointestinal Circulation – NCBI Bookshelf”.
  4. Hobson KG, Roberts PL (2004). “Etiology and pathophysiology of diverticular disease”. Clin Colon Rectal Surg. 17 (3): 147–53. doi:10.1055/s-2004-832695. PMC 2780060. PMID 20011269.
  5. Maykel JA, Opelka FG (2004). “Colonic diverticulosis and diverticular hemorrhage”. Clin Colon Rectal Surg. 17 (3): 195–204. doi:10.1055/s-2004-832702. PMC 2780065. PMID 20011276.
  6. Comparato G, Pilotto A, Franzè A, Franceschi M, Di Mario F (2007). “Diverticular disease in the elderly”. Dig Dis. 25 (2): 151–9. doi:10.1159/000099480. PMID 17468551.
  7. Matrana MR, Margolin DA (2009). “Epidemiology and pathophysiology of diverticular disease”. Clin Colon Rectal Surg. 22 (3): 141–6. doi:10.1055/s-0029-1236157. PMC 2780269. PMID 20676256.
  8. 8.0 8.1 8.2 Lohsiriwat V (2012). “Hemorrhoids: from basic pathophysiology to clinical management”. World J. Gastroenterol. 18 (17): 2009–17. doi:10.3748/wjg.v18.i17.2009. PMC 3342598. PMID 22563187.
  9. Sanchez C, Chinn BT (2011). “Hemorrhoids”. Clin Colon Rectal Surg. 24 (1): 5–13. doi:10.1055/s-0031-1272818. PMC 3140328. PMID 22379400.
  10. Holland RA, Rimes AF, Comis A, Tyndale-Biscoe CH (1988). “Oxygen carriage and carbonic anhydrase activity in the blood of a marsupial, the Tammar wallaby (Macropus eugenii), during early development”. Respir Physiol. 73 (1): 69–86. PMID 3140330.
  11. Krupski WC, Selzman CH, Whitehill TA (1997). “Unusual causes of mesenteric ischemia”. Surg. Clin. North Am. 77 (2): 471–502. PMID 9146726.
  12. Walker TG (2009). “Mesenteric ischemia”. Semin Intervent Radiol. 26 (3): 175–83. doi:10.1055/s-0029-1225662. PMC 3036494. PMID 21326562.
  13. Berland T, Oldenburg WA (2008). “Acute mesenteric ischemia”. Curr Gastroenterol Rep. 10 (3): 341–6. PMID 18625147.
  14. Mastoraki A, Mastoraki S, Tziava E, Touloumi S, Krinos N, Danias N, Lazaris A, Arkadopoulos N (2016). “Mesenteric ischemia: Pathogenesis and challenging diagnostic and therapeutic modalities”. World J Gastrointest Pathophysiol. 7 (1): 125–30. doi:10.4291/wjgp.v7.i1.125. PMC 4753178. PMID 26909235.
  15. FitzGerald JF, Hernandez Iii LO (2015). “Ischemic colitis”. Clin Colon Rectal Surg. 28 (2): 93–8. doi:10.1055/s-0035-1549099. PMC 4442720. PMID 26034405.
  16. Theodoropoulou A, Koutroubakis IE (2008). “Ischemic colitis: clinical practice in diagnosis and treatment”. World J. Gastroenterol. 14 (48): 7302–8. PMC 2778113. PMID 19109863.
  17. Rania H, Mériam S, Rym E, Hyafa R, Amine A, Najet BH, Lassad G, Mohamed TK (2014). “Ischemic colitis in five points: an update 2013”. Tunis Med. 92 (5): 299–303. PMID 25504381.
  18. Kim DH, Cheon JH (2017). “Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies”. Immune Netw. 17 (1): 25–40. doi:10.4110/in.2017.17.1.25. PMC 5334120. PMID 28261018.
  19. Hendrickson BA, Gokhale R, Cho JH (2002). “Clinical aspects and pathophysiology of inflammatory bowel disease”. Clin. Microbiol. Rev. 15 (1): 79–94. PMC 118061. PMID 11781268.
  20. Woźniak-Parnowska W, Werakso B (1974). “[Comparative studies of microbiological purity of ointments by the direct culture method and use of membrane filters]”. Acta Pol Pharm (in Polish). 31 (6): 819–23. PMID 4447044.
  21. Mazal J (2014). “Crohn disease: pathophysiology, diagnosis, and treatment”. Radiol Technol. 85 (3): 297–316, quiz 317–20. PMID 24395894.
  22. Jewell DP (1989). “Aetiology and pathogenesis of ulcerative colitis and Crohn’s disease”. Postgrad Med J. 65 (768): 718–9. PMC 2429831. PMID 2694136.
  23. 23.0 23.1 Sartor RB (2006). “Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis”. Nat Clin Pract Gastroenterol Hepatol. 3 (7): 390–407. doi:10.1038/ncpgasthep0528. PMID 16819502.
  24. Head K, Jurenka JS (2004). “Inflammatory bowel disease. Part II: Crohn’s disease–pathophysiology and conventional and alternative treatment options”. Altern Med Rev. 9 (4): 360–401. PMID 15656711.
  25. Zhang YZ, Li YY (2014). “Inflammatory bowel disease: pathogenesis”. World J. Gastroenterol. 20 (1): 91–9. doi:10.3748/wjg.v20.i1.91. PMC 3886036. PMID 24415861.
  26. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017). “Ulcerative colitis”. Lancet. 389 (10080): 1756–1770. doi:10.1016/S0140-6736(16)32126-2. PMID 27914657.
  27. Farrell RJ, Peppercorn MA (2002). “Ulcerative colitis”. Lancet. 359 (9303): 331–40. doi:10.1016/S0140-6736(02)07499-8. PMID 11830216.
  28. Rönnblom LE, Janson ET, Perers A, Oberg KE, Alm GV (1992). “Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment”. Clin. Exp. Immunol. 89 (3): 330–5. PMC 1554468. PMID 1516252.
  29. Itzkowitz S (2003). “Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice”. J. Clin. Gastroenterol. 36 (5 Suppl): S70–4, discussion S94–6. PMID 12702969.
  30. Ullman TA, Itzkowitz SH (2011). “Intestinal inflammation and cancer”. Gastroenterology. 140 (6): 1807–16. doi:10.1053/j.gastro.2011.01.057. PMID 21530747.
  31. Kraus S, Arber N (2009). “Inflammation and colorectal cancer”. Curr Opin Pharmacol. 9 (4): 405–10. doi:10.1016/j.coph.2009.06.006. PMID 19589728.
  32. Foutch PG (1993). “Angiodysplasia of the gastrointestinal tract”. Am. J. Gastroenterol. 88 (6): 807–18. PMID 8389094.
  33. Dodda G, Trotman BW (1997). “Gastrointestinal angiodysplasia”. J Assoc Acad Minor Phys. 8 (1): 16–9. PMID 9048468.
  34. Kheterpal S (1991). “Angiodysplasia: a review”. J R Soc Med. 84 (10): 615–8. PMC 1295562. PMID 1744847.
  35. Athanasoulis CA, Galdabini JJ, Waltman AC, Novelline RA, Greenfield AJ, Ezpeleta ML (1977). “Angiodysplasia of the colon: a cause of rectal bleeding”. Cardiovasc Radiol. 1 (1): 3–13. PMID 311247.
  36. Sami SS, Al-Araji SA, Ragunath K (2014). “Review article: gastrointestinal angiodysplasia – pathogenesis, diagnosis and management”. Aliment. Pharmacol. Ther. 39 (1): 15–34. doi:10.1111/apt.12527. PMID 24138285.
  37. West AB, Losada M (2004). “The pathology of diverticulosis coli”. J. Clin. Gastroenterol. 38 (5 Suppl 1): S11–6. PMID 15115923.
  38. Stamm B, Heer M, Bühler H, Ammann R (1985). “Mucosal biopsy of vascular ectasia (angiodysplasia) of the large bowel detected during routine colonoscopic examination”. Histopathology. 9 (6): 639–46. PMID 4029903.
  39. 39.0 39.1 Mitsudo S, Brandt LJ (1992). “Pathology of intestinal ischemia”. Surg. Clin. North Am. 72 (1): 43–63. PMID 1731389.
  40. Price AB, Morson BC (1975). “Inflammatory bowel disease: the surgical pathology of Crohn’s disease and ulcerative colitis”. Hum. Pathol. 6 (1): 7–29. PMID 1089084.
  41. Wright CL, Riddell RH (1998). “Histology of the stomach and duodenum in Crohn’s disease”. Am. J. Surg. Pathol. 22 (4): 383–90. PMID 9537465.
  42. DeRoche TC, Xiao SY, Liu X (2014). “Histological evaluation in ulcerative colitis”. Gastroenterol Rep (Oxf). 2 (3): 178–92. doi:10.1093/gastro/gou031. PMC 4124271. PMID 24942757.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Common causes of lower gastrointestinal tract bleeding include diverticulosis, angiodysplasia, ischemic colitis, colorectal cancer, anorectal diseases, infectious colitis and inflammatory bowel disease. Less common causes of lower gastrointestinal tract include colonic polyps, radiation proctitis, and rectal varices.

Causes

Common causes

Common causes of lower gastrointestinal bleeding inclue:[1][2][3][4][5][6][7][8][9][2][10]

Less common causes

Less common causes of lower gastrointestinal bleeding include:

References

  1. Bresci G (2009). “Occult and obscure gastrointestinal bleeding: Causes and diagnostic approach in 2009”. World J Gastrointest Endosc. 1 (1): 3–6. doi:10.4253/wjge.v1.i1.3. PMC 2999069. PMID 21160643.
  2. 2.0 2.1 Ghassemi KA, Jensen DM (2013). “Lower GI bleeding: epidemiology and management”. Curr Gastroenterol Rep. 15 (7): 333. doi:10.1007/s11894-013-0333-5. PMC 3857214. PMID 23737154.
  3. Hillemeier C, Gryboski JD (1984). “Gastrointestinal bleeding in the pediatric patient”. Yale J Biol Med. 57 (2): 135–47. PMC 2589822. PMID 6382833.
  4. Clouse RE, Costigan DJ, Mills BA, Zuckerman GR (1985). “Angiodysplasia as a cause of upper gastrointestinal bleeding”. Arch. Intern. Med. 145 (3): 458–61. PMID 3872107.
  5. Rockey DC (2010). “Occult and obscure gastrointestinal bleeding: causes and clinical management”. Nat Rev Gastroenterol Hepatol. 7 (5): 265–79. doi:10.1038/nrgastro.2010.42. PMID 20351759.
  6. “Hematemesis, Melena, and Hematochezia – Clinical Methods – NCBI Bookshelf”.
  7. Navuluri R, Kang L, Patel J, Van Ha T (2012). “Acute lower gastrointestinal bleeding”. Semin Intervent Radiol. 29 (3): 178–86. doi:10.1055/s-0032-1326926. PMC 3577586. PMID 23997409.
  8. Feinman M, Haut ER (2014). “Lower gastrointestinal bleeding”. Surg. Clin. North Am. 94 (1): 55–63. doi:10.1016/j.suc.2013.10.005. PMID 24267497.
  9. Zuccaro G (2008). “Epidemiology of lower gastrointestinal bleeding”. Best Pract Res Clin Gastroenterol. 22 (2): 225–32. doi:10.1016/j.bpg.2007.10.009. PMID 18346680.
  10. Zahmatkeshan M, Fallahzadeh E, Najib K, Geramizadeh B, Haghighat M, Imanieh MH (2012). “Etiology of lower gastrointestinal bleeding in children:a single center experience from southern iran”. Middle East J Dig Dis. 4 (4): 216–23. PMC 3990129. PMID 24829660.

Template:WH Template:WS

Differentiating Lower gastrointestinal bleeding from other Diseases

[[Image:Home_logo1.png|right|250px|link=

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Several diseases present with lower gastrointestinal bleeding and must be differented from each other. The common diseases responsible for lower GI bleeding inlcude diverticulosis, angiodysplasia, hemorrhoids, anal fissures, mesenteric Ischemia, ischemic colitis, inflammatory bowel disease, and colorectal carcinoma.

Differentiating Lower gastrointestinal bleeding from other Diseases

Several diseases present with lower gastrointestinal bleeding and must be differented from each other. The common diseases responsible for lower GI bleeding inlcude diverticulosis, angiodysplasia, hemorrhoids, anal fissures, mesenteric Ischemia, ischemic colitis, inflammatory bowel disease, and colorectal carcinoma.

Disease Symptoms Other features Diagnosis
Abdominal pain Rectal pain Weightloss Fever Type of GI bleeding Diarrhea Constipation Laboratory findings Radio-Imaging findings
Diverticulosis Red or maroon-colored blood +
  • Self limiting
  • Seen in elderly
Normal

Globular outpouchings on CT scan

Angiodysplasia Frank blood Normal Normal
Hemorrhoids + Blood on tissues + Tortuous dilated vessels on anoscopy
Anal fissures + Blood on tissues + Normal except mild leucocytosis Anoscopy
Mesenteric Ischemia + + + Frank blood +
  • Pain alters with eating habits
  • Associated with other comorbid conditions
Ischemic colitis + + Frank blood + 3 phases
  • Mild moderate diffuse bowel wall thickening
  • Marked hyperenhancement of the mucosa
Crohn’s disease + + + Blood mixed with stools + + Extra intestinal manifestations
Ulcerative colitis + + + + Blood mixed with stools + +
Colon carcinoma + -† + + Occult bleeding + +† + FOBT (fecal occult blood test)

↑ CEA( and CA 19-9

Hypercalcemia 

The following table differentiates all the diseases presenting with abdominal pain and lower gastrointestinal bleeding.

Abbreviations: RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram

Disease Clinical manifestations Diagnosis Comments
Symptoms Signs
Abdominal Pain Fever Rigors and chills Nausea or vomiting Jaundice Constipation Diarrhea Weight loss GI bleeding Hypo-

tension

Guarding Rebound Tenderness Bowel sounds Lab Findings Imaging
Acute diverticulitis LLQ + ± + + ± + Positive in perforated diverticulitis + + Hypoactive
  • CT scan
  • Ultrasound
Inflammatory bowel disease Diffuse ± ± + + + Normal or hyperactive

Extra intestinal findings:

Infective colitis Diffuse + ± + + Positive in fulminant colitis ± ± Hyperactive CT scan
  • Bowel wall thickening
  • Edema
Colon carcinoma Diffuse/localized ± ± + + ±
  • Normal or hyperactive if obstruction present
  • CBC
  • Carcinoembryonic antigen (CEA)
  • Colonoscopy
  • Flexible sigmoidoscopy
  • Barium enema
  • CT colonography 
  • PILLCAM 2: A colon capsule for CRC screening may be used in patients with an incomplete colonoscopy who lacks obstruction
Hemochromatosis RUQ Positive in cirrhotic patients N
  • >60% TS
  • >240 μg/L SF
  • Raised LFT
    Hyperglycemia
  • Ultrasound shows evidence of cirrhosis
Extra intestinal findings:
Mesenteric ischemia Periumbilical Positive if bowel becomes gangrenous + + + + Positive if bowel becomes gangrenous Positive if bowel becomes gangrenous Hyperactive to absent CT angiography
  • SMA or SMV thrombosis
  • Also known as abdominal angina that worsens with eating
Acute ischemic colitis Diffuse + ± + + + + + + + Hyperactive then absent Abdominal x-ray
  • Distension and pneumatosis

CT scan

  • Double halo appearance, thumbprinting
  • Thickening of bowel
  • May lead to shock
Ruptured abdominal aortic aneurysm Diffuse ± + + + + N
  • Focused Assessment with Sonography in Trauma (FAST) 
  • Unstable hemodynamics
Intra-abdominal or retroperitoneal hemorrhage Diffuse ± ± + + N
  • ↓ Hb
  • ↓ Hct
  • CT scan

References

Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

The prevalence of lower gastrointestinal bleeding is approximately 20 per 100,000 population in the United States. Lower gastrointestinal bleed is more common in men than women.

Epidemiology

Prevalence

  • The prevalence of lower gastrointestinal bleeding is approximately 20 per 100,000 population in the United States.[1][2]

Incidence

  • The estimated annual incidence of lower GI bleeding is approximately 0.03% in the adult population as a whole.
  • The overall incidence of lower GI bleeding is approximately 27 per 100,000 population in the United States.
Incidence of GI bleeding per 100,000 population.
Source: https://creativecommons.org/licenses/by-sa/4.0/

Demographics

Gender

  • Lower gastrointestinal bleed (LGIB) is more common in men than women.[1]

Race

  • There is no racial predilection to lower gastrointestinal bleeding.

Age

  • LGIB is rare in children.
  • The incidence of lower GI bleeding increases with age with a 200-fold increase from the second to eighth decades of life.
Incidence of GI bleeding based on age
Source:https://creativecommons.org/licenses/by-sa/4.0/

References

  1. 1.0 1.1 Ghassemi KA, Jensen DM (2013). “Lower GI bleeding: epidemiology and management”. Curr Gastroenterol Rep. 15 (7): 333. doi:10.1007/s11894-013-0333-5. PMC 3857214. PMID 23737154.
  2. Zuccaro G (2008). “Epidemiology of lower gastrointestinal bleeding”. Best Pract Res Clin Gastroenterol. 22 (2): 225–32. doi:10.1016/j.bpg.2007.10.009. PMID 18346680.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Common risk factors in the development of lower GI bleeding include advancing age, previous history of gastrointestinal bleeding, chronic constipation, hematologic disorders, medications such as anticoagulants, non-steroidal anti-inflammatory drugs, and human immunodeficiency virus infection.

Risk Factors

Common risk factors in the development of lower GI bleeding include:[1][2][3][4]

Risk factor Pathophysiology of bleeding
Chronic constipation Results in colonic diverticula and predispose patients to anal fissures and hemorrhoid formation
Hematologic disorders Deficiencies in clotting factors, such as factor VII and factor VIII, predispose to LGIB
Anticoagulants Patients taking warfarin, heparin, aspirin, and platelet inhibitors are at increased risk of bleeding in general
Nonsteroidal anti-inflammatory drugs NSAIDs cause ulceration in the terminal ileum and proximal colon, and can exacerbate IBD
Human immunodeficiency virus In patients with HIV, bleeding is caused by opportunistic infections, cytomegalovirus colitis, Kaposi sarcoma, or lymphoma

References

  1. Navuluri R, Kang L, Patel J, Van Ha T (2012). “Acute lower gastrointestinal bleeding”. Semin Intervent Radiol. 29 (3): 178–86. doi:10.1055/s-0032-1326926. PMC 3577586. PMID 23997409.
  2. Strate LL (2005). “Lower GI bleeding: epidemiology and diagnosis”. Gastroenterol. Clin. North Am. 34 (4): 643–64. doi:10.1016/j.gtc.2005.08.007. PMID 16303575.
  3. Ríos A, Montoya MJ, Rodríguez JM, Serrano A, Molina J, Ramírez P, Parrilla P (2007). “Severe acute lower gastrointestinal bleeding: risk factors for morbidity and mortality”. Langenbecks Arch Surg. 392 (2): 165–71. doi:10.1007/s00423-006-0117-6. PMID 17131153.
  4. Strate LL, Orav EJ, Syngal S (2003). “Early predictors of severity in acute lower intestinal tract bleeding”. Arch. Intern. Med. 163 (7): 838–43. doi:10.1001/archinte.163.7.838. PMID 12695275.

Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

There is insufficient evidence to recommend routine screening for lower gastrointestinal bleeding.

Screening

There is insufficient evidence to recommend routine screening for lower gastrointestinal bleeding.

References

Template:WH Template:WS

Natural History, Complications, and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

If left untreated, lower gastrointestinal bleeding is usually self-limited (90% of the time bleeding stops on its own). Massive blood loss can result in a severe drop in blood pressure resulting in decreased blood supply to organ systems leading to death. Hypovolemic shock and symptomatic anemia are the most common direct complications of LGIB. Prognosis is generally good, and the 1-year mortality rate of patients with lower gastrointestinal bleeding is less than 3%.

Natural History, Complications, and Prognosis

Natural History

If left untreated, lower gastrointestinal bleeding is usually self-limited (90% of the time bleeding stops on its own). Massive blood loss can result in a severe drop in blood pressure resulting in decreased blood supply to organ systems leading to death. Chronic blood loss if left untreated results in anemia.[1]

Complications

Common complications of LGIB include:[2][3]

  • Hypovolemic shock and symptomatic anemia are the most common direct complications of LGIB.
  • Rebleeding following treatment is not uncommon.
  • All treatment modalities have potential adverse affects:

Prognosis

  • Prognosis is generally good, and the 1 year mortality rate of patients with lower gastrointestinal bleeding is approximately <3%.[4][5]
  • With definitive intervention to treat or remove the source of blood loss, rebleeding rates are low.
  • Without definitive treatment, rebleeding rates can be appreciable, as high as 38%.

References

  1. Waggershauser CH, Storr M (2016). “[Lower gastrointestinal bleeding]”. MMW Fortschr Med (in German). 158 (9): 50–1. doi:10.1007/s15006-016-8208-y. PMID 27155708.
  2. Navuluri R, Kang L, Patel J, Van Ha T (2012). “Acute lower gastrointestinal bleeding”. Semin Intervent Radiol. 29 (3): 178–86. doi:10.1055/s-0032-1326926. PMC 3577586. PMID 23997409.
  3. Chait MM (2010). “Lower gastrointestinal bleeding in the elderly”. World J Gastrointest Endosc. 2 (5): 147–54. doi:10.4253/wjge.v2.i5.147. PMC 2998909. PMID 21160742.
  4. Sanfilippo G, Patanè R, Fusto A, Passanisi G, Valenti R, Russo A (1986). “Endoscopic approach to childhood coeliac disease”. Acta Gastroenterol. Belg. 49 (4): 401–8. PMID 3577609.
  5. “Lower gastrointestinal tract bleeding: a problem based approach – Surgical Treatment – NCBI Bookshelf”.

Template:WH Template:WS

Diagnosis

Diagnosis

Diagnostic study of choice | History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH